320725-47-1 Usage
Uses
Used in Pharmaceutical Industry:
(2S)-2-hydroxypropanoic acid (3beta,5alpha,7alpha,24R)-3-(3-[(4-aminobutyl)amino]propylamino)-7-hydroxycholestan-24-yl hydrogen sulfate (1:1) could be used as a pharmaceutical agent for [specific medical condition or treatment] due to its unique structure and functional groups that may interact with biological targets.
Used in Cosmetic Industry:
In the cosmetic industry, this compound might be utilized as an active ingredient for [specific cosmetic purpose], leveraging its potential effects on skin health or appearance, possibly due to the presence of the steroidal backbone and hydroxyl groups.
Used in Research Applications:
For research purposes, the compound could serve as a tool in biochemical and medicinal chemistry to study [specific biological processes or mechanisms], given its complex structure and potential for interaction with cellular components.
[Please replace the placeholders [specific medical condition or treatment], [specific cosmetic purpose], and [specific biological processes or mechanisms] with actual applications once they are identified or confirmed through research or expert consultation.]
Check Digit Verification of cas no
The CAS Registry Mumber 320725-47-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,0,7,2 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 320725-47:
(8*3)+(7*2)+(6*0)+(5*7)+(4*2)+(3*5)+(2*4)+(1*7)=111
111 % 10 = 1
So 320725-47-1 is a valid CAS Registry Number.
320725-47-1Relevant articles and documents
CRYSTALLINE FORMS OF SQUALAMINE
-
, (2021/09/26)
This disclosure provides crystalline polymorphs of squalamine phosphate, methods of making the same, and methods of treatment using the same.
NEW SQUALAMINE SOLID FORMS AND METHODS OF MAKING THE SAME
-
Paragraph 0228-0234, (2019/05/15)
Provided herein are crystalline solid forms of squalamine phosphate designated as Form 1 and Form 2, compositions containing one or both forms, and methods of their preparation and of their use.
Polymorphic and amorphous salt forms of squalamine dilactate
-
Page/Page column 10-11, (2010/11/25)
The invention relates to select squalamine salts, methods of their synthesis, their therapeutic use and their advantages relating to manufacturing, product stability and toxicity. More specifically, this application is directed to various forms of the dil
